Australia - English - Department of Health (Therapeutic Goods Administration)

american orthodontics aust/nz pty ltd - 31757 - orthodontic appliance, extra-oral headgear - short term devices for removable extraoral orthodontic appliances

Australia - English - Department of Health (Therapeutic Goods Administration)

american orthodontics aust/nz pty ltd - 65677 - orthodontic palate expander screw, bonded - long term and single use devices to be used as part in the manufacturing of fixed custom made palatal expander or other orthodontic expander to create space for teeth alignment and maintain teeth in corrected position.

Australia - English - Department of Health (Therapeutic Goods Administration)

american orthodontics aust/nz pty ltd - 35310 - orthodontic appliance, retainer - short term devices to be used in the manufacturing of removable orthodontic appliances for orthodontic treatment to shift and maintain teeth in corrected positions

Australia - English - Department of Health (Therapeutic Goods Administration)

american orthodontics aust/nz pty ltd - 64768 - orthodontic palate expander screw key - transient use instruments used during orthodontic procedures

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - american house dust mite extract, quantity: 5 ir/ml; european house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: sodium chloride; phenol; water for injections; aluminium hydroxide hydrate; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite extract, quantity: 5 ir/ml; american house dust mite extract, quantity: 5 ir/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; phenol; sodium chloride; water for injections; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - hydramethylnon - gel - hydramethylnon hydrazide active 20.0 g/kg - insecticide - commercial premises - general | domestic pest control | warehouse | factory | garden shed | homestead | houses | in and around | - american cockroach | australian cockroach | cockroach | german cockroach | oriental cockroach | smokeybrown cockroach | large cockroach | small cockroach

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite, quantity: 150 ir; american house dust mite, quantity: 150 ir - tablet - excipient ingredients: magnesium stearate; croscarmellose sodium; lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; mannitol - treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite, quantity: 150 ir; american house dust mite, quantity: 150 ir - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; mannitol - treatment of house dust mite allergic rhinitis with or without conjunctivitis in adults, adolescents and children 5 years and over diagnosed with house dust mite allergy.